Frontiers In Oncology - Antoni Ribas, Md, Phd

Frontiers in Oncology - Antoni Ribas, MD, PhD

Stanford Cancer Institute

Dr. Ribas on Combination Immunotherapy and Radiation in Melanoma

Frontiers in Oncology: Karen Winkfield, MD, PhD

Stanford Cancer Institute

Frontiers in Oncology: John Maris, MD

Stanford Cancer Institute

Dr. Antoni Ribas Discusses the Giants of Cancer Care Program

Using Immunotherapy Combinations With Increased Toxicities

Targeted Oncology

Frontiers in Oncology - Patricia Ganz, MD

Stanford Cancer Institute

AON 2024 | Leukemia and Myelodysplastic Syndromes — Harry Paul Erba, MD, PhD

Research To Practice

Melanoma Immunotherapy: What's Next for Patients? with Antoni Ribas

Cancer Research Institute

Frontiers in Oncology - Evis Sala, MD, PhD, FRCR

Stanford Cancer Institute

Dr. Ribas on Triplet Regimens in Melanoma

Dr. Antoni Ribas: 2015 Giants of Cancer Care Winner

Dr. Antoni Ribas on the Efficacy of Lambrolizumab in Advanced Melanoma

Targeted Oncology

AACR IO—Discovery & Innovation in Cancer Immunology: Revolutionizing Treatment Through Immunotherapy

American Association for Cancer Research

Empowering Tomorrow's Great Minds in Cancer Research Through Mentorship

Parker Institute for Cancer Immunotherapy

Dr. Ribas on PD-1 and PD-L1 in Cancer

Targeted Oncology

Dr. Ribas Discusses the Developmental Process of MK-3475 in Melanoma

Targeted Oncology

Program Chair Antoni Ribas, MD, PhD, Discusses the AACR Annual Meeting 2020

American Association for Cancer Research

Sequencing Agents for the Treatment of Patients With Melanoma

Targeted Oncology